Hwang, C., Henderson, N., Cackowski, F. C., Pilling, A., Jang, A., Rothstein, S., … Barata, P. C. (2022). Biomarker-directed therapy in black and white men with metastatic castration-resistant prostate cancer (mCRPC). In JOURNAL OF CLINICAL ONCOLOGY (Vol. 40).

Hwang, Clara, Nicholas Henderson, Frank Cameron Cackowski, Amanda Pilling, Albert Jang, Shoshana Rothstein, Matthew Labriola, et al. “Biomarker-directed therapy in black and white men with metastatic castration-resistant prostate cancer (mCRPC).” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 40, 2022.

Hwang C, Henderson N, Cackowski FC, Pilling A, Jang A, Rothstein S, et al. Biomarker-directed therapy in black and white men with metastatic castration-resistant prostate cancer (mCRPC). In: JOURNAL OF CLINICAL ONCOLOGY. 2022.

Hwang, Clara, et al. “Biomarker-directed therapy in black and white men with metastatic castration-resistant prostate cancer (mCRPC).” JOURNAL OF CLINICAL ONCOLOGY, vol. 40, no. 16, 2022.

Hwang C, Henderson N, Cackowski FC, Pilling A, Jang A, Rothstein S, Labriola M, Park JJ, Ghose A, Bilen MA, Kilari D, Tripathi A, Garje R, Koshkin VS, Schweizer MT, Armstrong AJ, Mckay RR, Dorff TB, Alva AS, Barata PC. Biomarker-directed therapy in black and white men with metastatic castration-resistant prostate cancer (mCRPC). JOURNAL OF CLINICAL ONCOLOGY. 2022.